Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 216

1.

Amyloid-β Related Memory Decline is not Associated with Subjective or Informant Rated Cognitive Impairment in Healthy Adults.

Hollands S, Lim YY, Buckley R, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Lautenschlager N, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P.

J Alzheimers Dis. 2014 Aug 11. [Epub ahead of print]

PMID:
25114076
[PubMed - as supplied by publisher]
2.

Dietary patterns and cognitive decline in an Australian study of ageing.

Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, Ames D, Keogh JB, Scarmeas N, Martins RN.

Mol Psychiatry. 2014 Jul 29. doi: 10.1038/mp.2014.79. [Epub ahead of print]

PMID:
25070537
[PubMed - as supplied by publisher]
3.

Functional Connectivity in Autosomal Dominant and Late-Onset Alzheimer Disease.

Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, Ourselin S, Schofield PR, Masters CL, Martins RN, Weiner MW, Thompson PM, Fox NC, Koeppe RA, Jack CR Jr, Mathis CA, Oliver A, Blazey TM, Moulder K, Buckles V, Hornbeck R, Chhatwal J, Schultz AP, Goate AM, Fagan AM, Cairns NJ, Marcus DS, Morris JC, Ances BM.

JAMA Neurol. 2014 Jul 28. doi: 10.1001/jamaneurol.2014.1654. [Epub ahead of print]

PMID:
25069482
[PubMed - as supplied by publisher]
4.

Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults.

Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Villemagne VL, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Szoeke C, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Ellis KA.

Int Psychogeriatr. 2014 Jun 27:1-10. [Epub ahead of print]

PMID:
24969443
[PubMed - as supplied by publisher]
5.

An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation.

Rembach A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD; AIBL Research Group.

J Neuroimmunol. 2014 Aug 15;273(1-2):65-71. doi: 10.1016/j.jneuroim.2014.05.005. Epub 2014 May 20.

PMID:
24907904
[PubMed - in process]
6.

The involvement of lipids in Alzheimer's disease.

Lim WL, Martins IJ, Martins RN.

J Genet Genomics. 2014 May 20;41(5):261-74. doi: 10.1016/j.jgg.2014.04.003. Epub 2014 May 2.

PMID:
24894353
[PubMed - in process]
7.

Incidence of cerebral microbleeds in preclinical Alzheimer disease.

Yates PA, Desmond PM, Phal PM, Steward C, Szoeke C, Salvado O, Ellis KA, Martins RN, Masters CL, Ames D, Villemagne VL, Rowe CC; AIBL Research Group.

Neurology. 2014 Apr 8;82(14):1266-73. doi: 10.1212/WNL.0000000000000285. Epub 2014 Mar 12.

PMID:
24623839
[PubMed - indexed for MEDLINE]
8.

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.

Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, Marcus D, Cairns NJ, Buckles VD, Ladenson JH, Morris JC, Holtzman DM; Dominantly Inherited Alzheimer Network.

Sci Transl Med. 2014 Mar 5;6(226):226ra30. doi: 10.1126/scitranslmed.3007901.

PMID:
24598588
[PubMed - in process]
9.

Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease.

Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC; AIBL Research Group.

Alzheimers Dement. 2014 Feb 28. pii: S1552-5260(13)02939-7. doi: 10.1016/j.jalz.2013.11.005. [Epub ahead of print]

PMID:
24589436
[PubMed - as supplied by publisher]
10.

Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study.

Pietrzak RH, Scott JC, Neumeister A, Lim YY, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group.

Br J Psychiatry. 2014 May;204:400-1. doi: 10.1192/bjp.bp.113.134239. Epub 2014 Feb 13.

PMID:
24526746
[PubMed - in process]
11.

Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing.

Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Szoeke C, Ellis KA.

J Alzheimers Dis. 2014;40(3):551-61. doi: 10.3233/JAD-131820.

PMID:
24496075
[PubMed - in process]
12.

Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study.

Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington K, Bourgeat P, Bush AI, Martins RN, Masters CL, Rowe CC, Maruff P; AIBL Research Group.

PLoS One. 2014 Jan 27;9(1):e86498. doi: 10.1371/journal.pone.0086498. eCollection 2014.

PMID:
24475133
[PubMed - in process]
Free PMC Article
13.

An anemia of Alzheimer's disease.

Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL; The AIBL Research Group, Bush AI.

Mol Psychiatry. 2014 Jan 14. doi: 10.1038/mp.2013.178. [Epub ahead of print]

PMID:
24419041
[PubMed - as supplied by publisher]
14.

Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.

Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD; AIBL Research Group.

J Alzheimers Dis. 2014;40(1):95-104. doi: 10.3233/JAD-131802.

PMID:
24334723
[PubMed - in process]
15.

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases.

Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G.

Transl Psychiatry. 2013 Dec 3;3:e332. doi: 10.1038/tp.2013.97. Review.

PMID:
24301650
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).

Ellis KA, Szoeke C, Bush AI, Darby D, Graham PL, Lautenschlager NT, Macaulay SL, Martins RN, Maruff P, Masters CL, McBride SJ, Pike KE, Rainey-Smith SR, Rembach A, Robertson J, Rowe CC, Savage G, Villemagne VL, Woodward M, Wilson W, Zhang P, Ames D; AIBL Research Group.

Int Psychogeriatr. 2014 Apr;26(4):543-54. doi: 10.1017/S1041610213001956. Epub 2013 Nov 20.

PMID:
24252258
[PubMed - in process]
17.

Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts.

Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, Boundy K, Ellis KA, Bush AI, Faux NG, Martins RN, Masters CL, Rowe CC, Szoeke C, Watters DA.

J Alzheimers Dis. 2014;39(3):661-8. doi: 10.3233/JAD-131265.

PMID:
24246419
[PubMed - in process]
18.

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.

Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC; AIBL Research Group.

Brain. 2014 Jan;137(Pt 1):221-31. doi: 10.1093/brain/awt286. Epub 2013 Oct 30.

PMID:
24176981
[PubMed - indexed for MEDLINE]
19.

Pupil response biomarkers for early detection and monitoring of Alzheimer's disease.

Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN; AIBL Research Group.

Curr Alzheimer Res. 2013 Nov;10(9):931-9.

PMID:
24117119
[PubMed - indexed for MEDLINE]
20.

Differential, dominant activation and inhibition of Notch signalling and APP cleavage by truncations of PSEN1 in human disease.

Newman M, Wilson L, Verdile G, Lim A, Khan I, Moussavi Nik SH, Pursglove S, Chapman G, Martins RN, Lardelli M.

Hum Mol Genet. 2014 Feb 1;23(3):602-17. doi: 10.1093/hmg/ddt448. Epub 2013 Sep 18.

PMID:
24101600
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk